Alan Wills is responsible for strategy, business development and portfolio management activities at CSL Behring.
Alan joined CSL Behring as SVP Strategy and Business Development in 2015. Prior to joining CSL, he was EVP, Corporate Development at Auxilium Pharmaceuticals. He was also head of corporate strategy for Bristol-Myers Squibb and Pfizer, and he has worked in strategy and business development roles at United Healthcare and Stanford Medical Center. Alan began his career with the Boston Consulting Group.
He holds a bachelor’s degree in zoology from Oxford University and a Master of Business Administration from Harvard Business School.